| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 25.815 | 61.275 | 108.909 | 95.168 | 73.469 | 245.464 | 384.806 |
| Total Income - EUR | - | - | - | 25.815 | 61.275 | 108.909 | 95.293 | 93.191 | 257.748 | 385.051 |
| Total Expenses - EUR | - | - | - | 6.513 | 26.192 | 22.471 | 27.745 | 48.026 | 90.732 | 104.168 |
| Gross Profit/Loss - EUR | - | - | - | 19.302 | 35.083 | 86.439 | 67.548 | 45.164 | 167.016 | 280.883 |
| Net Profit/Loss - EUR | - | - | - | 19.044 | 34.470 | 85.435 | 66.614 | 44.253 | 143.845 | 242.306 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Dab Pharmservice S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 24.174 | 17.743 | 31.406 | 22.364 | 14.918 | 6.431 | 5.424 |
| Current Assets | - | - | - | 16.147 | 17.927 | 60.500 | 64.120 | 53.793 | 171.544 | 285.932 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 2.003 | 3.008 | 42.930 | 62.088 | 51.900 | 32.304 | 82.025 |
| Cash | - | - | - | 14.145 | 14.919 | 17.571 | 2.033 | 1.893 | 139.239 | 203.907 |
| Shareholders Funds | - | - | - | 19.087 | 34.521 | 85.484 | 66.663 | 44.301 | 144.049 | 276.796 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 21.235 | 1.149 | 6.422 | 20.224 | 24.316 | 33.925 | 14.560 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 94 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Dab Pharmservice S.r.l.